GOSH and Oliver Patch in cancer research partnership with Innovative Trials

Globally 400,000 children are impacted every year by cancers that include leukaemia and lymphoma

UK’s Great Ormond Street Hospital (GOSH) Children’s Charity and the Oliver Patch Project in the US have come together with Innovative Trials to form two strategic partnerships to accelerate research into childhood cancers.

Innovative Trials has been working with the Oliver Patch Project and the GOSH charity since last year.

Leukaemia and lymphoma are two of the most common childhood cancers that affect more than 6,000 children in the UK and US, and approximately 400,000 children globally, every year.

In the UK, Innovative Trials has committed to raising money towards Gosh Charity’s Build it. Beat it. appeal, which aims to raise £300m to help build a new Children’s Cancer Centre at GOSH designed to provide increased capacity for research studies and drive transformation in children’s cancer care.

In the US, Innovative Trials has committed to donating $6 to the Oliver Patch Project every time a child or teenager enrols in a paediatric clinical trial where the sponsor has commissioned Innovative Trials’ Retention Patch Program, as well as raising money for the US non-profit at industry events and through internal fundraising activities.

As part of its Patches of Positive Program, the Oliver Patch Project provides children who are enrolled in one of the organisation’s programmes with colourful and collectable-designed patches throughout their treatment journey, in addition to monthly collectable cards, animations and colouring sheets.